{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:16:13Z","timestamp":1783487773705,"version":"3.55.0"},"reference-count":65,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0414","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T22:03:59Z","timestamp":1579903439000},"page":"241-248","source":"Crossref","is-referenced-by-count":25,"title":["Solid variant of papillary thyroid carcinoma: an under-recognized entity"],"prefix":"10.1507","volume":"67","author":[{"given":"Ryuji","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Nippon Medical School Musashi-Kosugi Hospital, Kanagawa 211-8533, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Rosai J, Albores Saavedra J, Asioli S, Baloch ZW, Bogdanova T, et al. (2017) In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (ed) WHO classification of tumours of endocrine organs, WHO\/IARC classification of tumours (4<sup>th<\/sup>), vol 10. International Agent for Research on Cancer. World Health Organization, Lyon: 81\u201391."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lam AK, Lo CY, Lam KS (2005) Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol 16: 323\u2013330.","DOI":"10.1385\/EP:16:4:323"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Nath MC, Erickson LA (2018) Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv Anat Pathol 25: 172\u2013179.","DOI":"10.1097\/PAP.0000000000000184"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ferreiro JA, Hay ID, Lloyd RV (1996) Columnar cell carcinoma of the thyroid: report of three additional cases. Hum Pathol 27: 1156\u20131160.","DOI":"10.1016\/S0046-8177(96)90308-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25: 1478\u20131484.","DOI":"10.1097\/00000478-200112000-00002"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J (1985) Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55: 805\u2013828.","DOI":"10.1002\/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO;2-Z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hawk WA, Hazard JB (1976) The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 43: 207\u2013215.","DOI":"10.3949\/ccjm.43.4.207"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tscholl-Ducommun J, Hedinger CE (1982) Papillary thyroid carcinomas. Morphology and prognosis. Virchows Arch A Pathol Anat Histol 396: 19\u201339.","DOI":"10.1007\/BF00428498"},{"key":"9","unstructured":"9 Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57: 1690\u20131694."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Trovisco V, Soares P, Soares R, Magalh\u00e3es J, S\u00e1-Couto P, et al. (2005) A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 36: 694\u2013697.","DOI":"10.1016\/j.humpath.2005.04.011"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chiosea S, Nikiforova M, Zuo H, Ogilvie J, Gandhi M, et al. (2009) A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol 20: 122\u2013126.","DOI":"10.1007\/s12022-009-9073-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ohashi R, Kawahara K, Namimatsu S, Igarashi T, Sakatani T, et al. (2017) Clinicopathological significance of a solid component in papillary thyroid carcinoma. Histopathology 70: 775\u2013781.","DOI":"10.1111\/his.13132"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, et al. (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2: 1023\u20131029.","DOI":"10.1001\/jamaoncol.2016.0386"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Volante M, Rapa I, Papotti M (2008) Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues. Endocr Pathol 19: 150\u2013155.","DOI":"10.1007\/s12022-008-9040-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yi KS, Kim JH, Na DG, Seo H, Min HS, et al. (2015) Usefulness of core needle biopsy for thyroid nodules with macrocalcifications: comparison with fine-needle aspiration. Thyroid 25: 657\u2013664.","DOI":"10.1089\/thy.2014.0596"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Troncone G, Russo M, Malapelle U, Accardo M, Ferraro A, et al. (2008) Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: a case report. Cytojournal 5: 2.","DOI":"10.1186\/1742-6413-5-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Giorgadze TA, Scognamiglio T, Yang GC (2015) Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations. Cancer Cytopathol 123: 71\u201381.","DOI":"10.1002\/cncy.21504"},{"key":"18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/cyt.12399","volume":"28","author":"M Higuchi","year":"2017","unstructured":"18 Higuchi M, Hirokawa M, Suzuki A, Takada N, Yamao N, et al. (2017) Cytological features of solid variants of papillary thyroid carcinoma: a fine needle aspiration cytology study of 18 cases. Cytopathology 28: 268\u2013272.","journal-title":"Cytopathology","ISSN":"https:\/\/id.crossref.org\/issn\/0956-5507","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Ohashi R (2019) Solid\/Trabecular variant of papillary thyroid carcinoma. In: Kakudo K (ed) Thyroid FNA Cytology. Springer, 249\u2013253.","DOI":"10.1007\/978-981-13-1897-9_31"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Guleria P, Phulware R, Agarwal S, Jain D, Mathur SR, et al. (2018) Cytopathology of solid variant of papillary thyroid carcinoma: differential diagnoses with other thyroid tumors. Acta Cytol 62: 371\u2013379.","DOI":"10.1159\/000493081"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Ohashi R, Murase Y, Matsubara M, Watarai Y, Igarashi T, et al. (2017) Fine needle aspiration cytology of the papillary thyroid carcinoma with a solid component: a cytological and clinical correlation. Diagn Cytopathol 45: 391\u2013398.","DOI":"10.1002\/dc.23679"},{"key":"22","first-page":"185","volume":"117","author":"M Bongiovanni","year":"2009","unstructured":"22 Bongiovanni M, Bloom L, Krane JF, Baloch ZW, Powers CN, et al. (2009) Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer 117: 185\u2013194.","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kane SV, Sharma TP (2015) Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study. Cancer Cytopathol 123: 82\u201391.","DOI":"10.1002\/cncy.21500"},{"key":"24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cyt.12270","volume":"27","author":"S Purkait","year":"2016","unstructured":"24 Purkait S, Agarwal S, Mathur SR, Jain D, Iyer VK (2016) Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma. Cytopathology 27: 176\u2013184.","journal-title":"Cytopathology","ISSN":"https:\/\/id.crossref.org\/issn\/0956-5507","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Chung D, Ghossein RA, Lin O (2007) Macrofollicular variant of papillary carcinoma: a potential thyroid FNA pitfall. Diagn Cytopathol 35: 560\u2013564.","DOI":"10.1002\/dc.20702"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW (2000) Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 8: 189\u2013194.","DOI":"10.1097\/00129039-200009000-00004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R (2008) Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol 21: 192\u2013200.","DOI":"10.1038\/modpathol.3801002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Bishop JA, Sharma R, Westra WH (2011) PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol 42: 1873\u20131877.","DOI":"10.1016\/j.humpath.2011.02.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 El Demellawy D, Nasr A, Alowami S (2008) Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diagn Pathol 3: 5.","DOI":"10.1186\/1746-1596-3-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Erkili\u00e7 S, Ko\u00e7er NE (2005) The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves\u2019 disease. Endocr Pathol 16: 63\u201366.","DOI":"10.1385\/EP:16:1:063"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, et al. (2005) Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18: 48\u201357.","DOI":"10.1038\/modpathol.3800235"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Casey MB, Lohse CM, Lloyd RV (2003) Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol 14: 55\u201360.","DOI":"10.1385\/EP:14:1:55"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, et al. (2010) Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol 21: 80\u201389.","DOI":"10.1007\/s12022-010-9114-y"},{"key":"34","unstructured":"34 Miettinen M, K\u00e4rkk\u00e4inen P (1996) Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch 429: 213\u2013219."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, et al. (2000) The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 13: 882\u2013887.","DOI":"10.1038\/modpathol.3880157"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Rossi ED, Straccia P, Palumbo M, Stigliano E, Revelli L, et al. (2013) Diagnostic and prognostic role of HBME-1, galectin-3, and \u03b2-catenin in poorly differentiated and anaplastic thyroid carcinomas. Appl Immunohistochem Mol Morphol 21: 237\u2013241.","DOI":"10.1097\/PAI.0b013e3182688d0f"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Isic Dencic T, Cvejic D, Paunovic I, Tatic S, Havelka M, et al. (2013) Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior. Med Oncol 30: 362.","DOI":"10.1007\/s12032-012-0362-1"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Yun JY, Kim YA, Choe JY, Min H, Lee KS, et al. (2014) Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. J Clin Pathol 67: 125\u2013133.","DOI":"10.1136\/jclinpath-2013-201711"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Deeken-Draisey A, Yang GY, Gao J, Alexiev BA (2018) Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol 82: 140\u2013148.","DOI":"10.1016\/j.humpath.2018.07.027"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40 Dettmer MS, Schmitt A, Komminoth P, Perren A (2019) Poorly differentiated thyroid carcinoma: an underdiagnosed entity. Pathologe. doi: 10.1007\/s00292-019-0600-9. [Epub ahead of print]","DOI":"10.1007\/s00292-019-0600-9"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Kakudo K, Wakasa T, Ohta Y, Yane K, Ito Y, et al. (2015) Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas. Endocr J 62: 1\u201312.","DOI":"10.1507\/endocrj.EJ14-0293"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Ohashi R, Kawahara K, Namimatsu S, Okamura R, Igarashi T, et al. (2017) Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component. Hum Pathol 67: 11\u201317.","DOI":"10.1016\/j.humpath.2017.03.012"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17: 313\u2013319.","DOI":"10.1038\/nm.2304"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Sato R, Semba T, Saya H, Arima Y (2016) Concise review: stem cells and epithelial-mesenchymal transition in cancer: biological implications and therapeutic targets. Stem Cells 34: 1997\u20132007.","DOI":"10.1002\/stem.2406"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Deng J, Wang L, Chen H, Hao J, Ni J, et al. (2016) Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer. Oncotarget 7: 55771\u201355788.","DOI":"10.18632\/oncotarget.9908"},{"key":"46","unstructured":"46 Guo Z, Hardin H, Lloyd RV (2014) Cancer stem-like cells and thyroid cancer. Endocr Relat Cancer 21: T285\u2013T300."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, et al. (2013) Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Thyroid 23: 829\u2013837.","DOI":"10.1089\/thy.2012.0372"},{"key":"48","unstructured":"48 Li W, Reeb AN, Sewell WA, Elhomsy G, Lin RY (2013) Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells. PLoS One 8: e65095."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Decaussin-Petrucci M, Delado\u00eby J, Hafdi-Nejjari Z, Sassolas G, Borson-Chazot F, et al. (2015) Expression of CD133 in differentiated thyroid cancer of young patients. J Clin Pathol 68: 434\u2013440.","DOI":"10.1136\/jclinpath-2014-202625"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL (2014) Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J Clin Endocrinol Metab 99: 536\u2013544.","DOI":"10.1210\/jc.2013-2558"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51 Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, et al. (2005) Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24: 6646\u20136656.","DOI":"10.1038\/sj.onc.1208822"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, et al. (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30: 216\u2013222.","DOI":"10.1097\/01.pas.0000176432.73455.1b"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, et al. (1999) High prevalence of RET\/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET\/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84: 4232\u20134238.","DOI":"10.1210\/jc.84.11.4232"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, et al. (2003) Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88: 4393\u20134397.","DOI":"10.1210\/jc.2003-030305"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, et al. (2012) The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab 97: 4390\u20134398.","DOI":"10.1210\/jc.2012-1775"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, et al. (2015) Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 33: 42\u201350.","DOI":"10.1200\/JCO.2014.56.8253"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12: 245\u2013262.","DOI":"10.1677\/erc.1.0978"},{"key":"58","first-page":"159","volume":"4","author":"NR Lemoine","year":"1989","unstructured":"58 Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, et al. (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4: 159\u2013164.","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"key":"59","unstructured":"59 Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, et al. (1994) N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 116: 1010\u20131016."},{"key":"60","unstructured":"60 Li W, Sun D, Ming H, Zhang G, Tan J (2017) A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases. Medicine (Baltimore) 96: e6086."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, et al. (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30: 1420\u20131426.","DOI":"10.1097\/01.pas.0000213264.07597.9a"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Vuong HG, Odate T, Duong UNP, Mochizuki K, Nakazawa T, et al. (2018) Prognostic importance of solid variant papillary thyroid carcinoma: a systematic review and meta-analysis. Head Neck 40: 1588\u20131597.","DOI":"10.1002\/hed.25123"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, et al. (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384: 319\u2013328.","DOI":"10.1016\/S0140-6736(14)60421-9"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, et al. (2015) Lenvatinib <i>versus<\/i> placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372: 621\u2013630.","DOI":"10.1056\/NEJMoa1406470"},{"key":"65","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1089\/thy.2016.0621","volume":"27","author":"Y Ito","year":"2017","unstructured":"65 Ito Y, Onoda N, Ito KI, Sugitani I, Takahashi S, et al. (2017) Sorafenib in Japanese patients with locally advanced or metastatic medullary thyroid carcinoma and anaplastic thyroid carcinoma. Thyroid 27: 1142\u20131148.","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/3\/67_EJ19-0414\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T22:33:07Z","timestamp":1614119587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/3\/67_EJ19-0414\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0414","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}